Apyx Medical Execs to Present at Canaccord Growth Conference
Event summary
- Apyx Medical execs to participate in Canaccord Growth Conference on August 11, 2026.
- CEO Charlie Goodwin and CFO Matt Hill will lead a fireside chat at 2:30pm ET.
- One-on-one investor meetings scheduled throughout the day.
- Webcast available live; replay posted on Investor Relations site.
The big picture
Apyx Medical's participation in the Canaccord Growth Conference underscores its focus on engaging institutional investors amid a broader push for surgical aesthetics innovation. The event comes as competitors intensify R&D spending, making Apyx's ability to articulate its technological edge critical. With over 90 clinical documents supporting its products, the company aims to reinforce its position in both cosmetic and hospital surgical markets.
What we're watching
- Market Positioning
- How Apyx Medical will emphasize its Renuvion and AYON systems' differentiation in a competitive surgical aesthetics market.
- Investor Sentiment
- Whether the executive presentations will shift investor perceptions of Apyx's growth trajectory.
- Product Adoption
- The pace at which AYON Body Contouring System gains traction among surgeons post-FDA clearance.
Related topics